[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2018-2023 Global Necrotizing Fasciitis Market Report (Status and Outlook)

October 2018 | 119 pages | ID: 21164C6537CEN
LP Information

US$ 4,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information studies the present scenario (with the base year being 2017) and the growth prospects of global Necrotizing Fasciitis market for 2018-2023.

Necrotizing fasciitis (NF), commonly known as flesh-eating disease, is an infection that results in the death of the body's soft tissue. It is a severe disease of sudden onset that spreads rapidly. Symptoms include red or purple skin in the affected area, severe pain, fever, and vomiting. The most commonly affected areas are the limbs and perineum.
Necrotizing fasciitis affects 0.4 to 1.0 person per 100,000 per year. Both sexes are affected equally. It becomes more common among older people and is very rare in children. Surgical debridement (cutting away affected tissue) is the mainstay of treatment for necrotizing fasciitis. Early medical treatment is often presumptive; thus, antibiotics should be started as soon as this condition is suspected. Cultures are taken to determine appropriate antibiotic coverage, and antibiotics may be changed when culture results are obtained. Besides blood pressure control and hydration, support should be initiated for those with unstable vital signs and low urine output.
Over the next five years, LPI(LP Information) projects that Necrotizing Fasciitis will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares and growth opportunities of Necrotizing Fasciitis market by product type, application, key companies and key regions.

To calculate the market size, LP Information considers value generated from the sales of the following segments:

Segmentation by product type:
  • Type I
  • Type II
Segmentation by application:
  • Hospital & Clinics
  • Surgical Centers
We can also provide the customized separate regional or country-level reports, for the following regions:
  • Americas
  • United States
  • Canada
  • Mexico
  • Brazil
  • APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Spain
  • Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:
  • Merck
  • Wockhardt
  • Atox Bio
  • Teva Pharmaceutical Industries
  • Basilea Pharmaceutica
  • Melinta Therapeutics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
  • To study and analyze the global Necrotizing Fasciitis market size by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
  • To understand the structure of Necrotizing Fasciitis market by identifying its various subsegments.
  • Focuses on the key global Necrotizing Fasciitis players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
  • To analyze the Necrotizing Fasciitis with respect to individual growth trends, future prospects, and their contribution to the total market.
  • To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
  • To project the size of Necrotizing Fasciitis submarkets, with respect to key regions (along with their respective key countries).
  • To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.
  • To strategically profile the key players and comprehensively analyze their growth strategies.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Necrotizing Fasciitis Market Size 2013-2023
  2.1.2 Necrotizing Fasciitis Market Size CAGR by Region
2.2 Necrotizing Fasciitis Segment by Type
  2.2.1 Type I
  2.2.2 Type II
  2.2.3 Type III
2.3 Necrotizing Fasciitis Market Size by Type
  2.3.1 Global Necrotizing Fasciitis Market Size Market Share by Type (2013-2018)
  2.3.2 Global Necrotizing Fasciitis Market Size Growth Rate by Type (2013-2018)
2.4 Necrotizing Fasciitis Segment by Application
  2.4.1 Hospital & Clinics
  2.4.2 Surgical Centers
2.5 Necrotizing Fasciitis Market Size by Application
  2.5.1 Global Necrotizing Fasciitis Market Size Market Share by Application (2013-2018)
  2.5.2 Global Necrotizing Fasciitis Market Size Growth Rate by Application (2013-2018)

3 GLOBAL NECROTIZING FASCIITIS BY PLAYERS

3.1 Global Necrotizing Fasciitis Market Size Market Share by Players
  3.1.1 Global Necrotizing Fasciitis Market Size by Players (2016-2018)
  3.1.2 Global Necrotizing Fasciitis Market Size Market Share by Players (2016-2018)
3.2 Global Necrotizing Fasciitis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 NECROTIZING FASCIITIS BY REGIONS

4.1 Necrotizing Fasciitis Market Size by Regions
4.2 Americas Necrotizing Fasciitis Market Size Growth
4.3 APAC Necrotizing Fasciitis Market Size Growth
4.4 Europe Necrotizing Fasciitis Market Size Growth
4.5 Middle East & Africa Necrotizing Fasciitis Market Size Growth

5 AMERICAS

5.1 Americas Necrotizing Fasciitis Market Size by Countries
5.2 Americas Necrotizing Fasciitis Market Size by Type
5.3 Americas Necrotizing Fasciitis Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Necrotizing Fasciitis Market Size by Countries
6.2 APAC Necrotizing Fasciitis Market Size by Type
6.3 APAC Necrotizing Fasciitis Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Necrotizing Fasciitis by Countries
7.2 Europe Necrotizing Fasciitis Market Size by Type
7.3 Europe Necrotizing Fasciitis Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Necrotizing Fasciitis by Countries
8.2 Middle East & Africa Necrotizing Fasciitis Market Size by Type
8.3 Middle East & Africa Necrotizing Fasciitis Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL NECROTIZING FASCIITIS MARKET FORECAST

10.1 Global Necrotizing Fasciitis Market Size Forecast (2018-2023)
10.2 Global Necrotizing Fasciitis Forecast by Regions
  10.2.1 Global Necrotizing Fasciitis Forecast by Regions (2018-2023)
  10.2.2 Americas Market Forecast
  10.2.3 APAC Market Forecast
  10.2.4 Europe Market Forecast
  10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
  10.3.1 United States Market Forecast
  10.3.2 Canada Market Forecast
  10.3.3 Mexico Market Forecast
  10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
  10.4.1 China Market Forecast
  10.4.2 Japan Market Forecast
  10.4.3 Korea Market Forecast
  10.4.4 Southeast Asia Market Forecast
  10.4.5 India Market Forecast
  10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
  10.5.1 Germany Market Forecast
  10.5.2 France Market Forecast
  10.5.3 UK Market Forecast
  10.5.4 Italy Market Forecast
  10.5.5 Russia Market Forecast
  10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
  10.6.1 Egypt Market Forecast
  10.6.2 South Africa Market Forecast
  10.6.3 Israel Market Forecast
  10.6.4 Turkey Market Forecast
  10.6.5 GCC Countries Market Forecast
10.7 Global Necrotizing Fasciitis Forecast by Type
10.8 Global Necrotizing Fasciitis Forecast by Application

11 KEY PLAYERS ANALYSIS

11.1 Merck
  11.1.1 Company Details
  11.1.2 Necrotizing Fasciitis Product Offered
  11.1.3 Merck Necrotizing Fasciitis Revenue, Gross Margin and Market Share (2016-2018)
  11.1.4 Main Business Overview
  11.1.5 Merck News
11.2 Wockhardt
  11.2.1 Company Details
  11.2.2 Necrotizing Fasciitis Product Offered
  11.2.3 Wockhardt Necrotizing Fasciitis Revenue, Gross Margin and Market Share (2016-2018)
  11.2.4 Main Business Overview
  11.2.5 Wockhardt News
11.3 Atox Bio
  11.3.1 Company Details
  11.3.2 Necrotizing Fasciitis Product Offered
  11.3.3 Atox Bio Necrotizing Fasciitis Revenue, Gross Margin and Market Share (2016-2018)
  11.3.4 Main Business Overview
  11.3.5 Atox Bio News
11.4 Teva Pharmaceutical Industries
  11.4.1 Company Details
  11.4.2 Necrotizing Fasciitis Product Offered
  11.4.3 Teva Pharmaceutical Industries Necrotizing Fasciitis Revenue, Gross Margin and Market Share (2016-2018)
  11.4.4 Main Business Overview
  11.4.5 Teva Pharmaceutical Industries News
11.5 Basilea Pharmaceutica
  11.5.1 Company Details
  11.5.2 Necrotizing Fasciitis Product Offered
  11.5.3 Basilea Pharmaceutica Necrotizing Fasciitis Revenue, Gross Margin and Market Share (2016-2018)
  11.5.4 Main Business Overview
  11.5.5 Basilea Pharmaceutica News
11.6 Melinta Therapeutics
  11.6.1 Company Details
  11.6.2 Necrotizing Fasciitis Product Offered
  11.6.3 Melinta Therapeutics Necrotizing Fasciitis Revenue, Gross Margin and Market Share (2016-2018)
  11.6.4 Main Business Overview
  11.6.5 Melinta Therapeutics News

12 RESEARCH FINDINGS AND CONCLUSION

LIST OF TABLES AND FIGURES

Table Product Specifications of Necrotizing Fasciitis
Figure Necrotizing Fasciitis Report Years Considered
Figure Market Research Methodology
Figure Global Necrotizing Fasciitis Market Size Growth Rate 2013-2023 ($ Millions)
Table Necrotizing Fasciitis Market Size CAGR by Region 2013-2023 ($ Millions)
Table Major Players of Type I
Table Major Players of Type II
Table Major Players of Type III
Table Market Size by Type (2013-2018) ($ Millions)
Table Global Necrotizing Fasciitis Market Size Market Share by Type (2013-2018)
Figure Global Necrotizing Fasciitis Market Size Market Share by Type (2013-2018)
Figure Global Type I Market Size Growth Rate
Figure Global Type II Market Size Growth Rate
Figure Global Type III Market Size Growth Rate
Figure Necrotizing Fasciitis Consumed in Hospital & Clinics
Figure Global Necrotizing Fasciitis Market: Hospital & Clinics (2013-2018) ($ Millions)
Figure Global Hospital & Clinics YoY Growth ($ Millions)
Figure Necrotizing Fasciitis Consumed in Surgical Centers
Figure Global Necrotizing Fasciitis Market: Surgical Centers (2013-2018) ($ Millions)
Figure Global Surgical Centers YoY Growth ($ Millions)
Table Global Necrotizing Fasciitis Market Size by Application (2013-2018) ($ Millions)
Table Global Necrotizing Fasciitis Market Size Market Share by Application (2013-2018)
Figure Global Necrotizing Fasciitis Market Size Market Share by Application (2013-2018)
Figure Global Necrotizing Fasciitis Market Size in Hospital & Clinics Growth Rate
Figure Global Necrotizing Fasciitis Market Size in Surgical Centers Growth Rate
Table Global Necrotizing Fasciitis Revenue by Players (2016-2018) ($ Millions)
Table Global Necrotizing Fasciitis Revenue Market Share by Players (2016-2018)
Figure Global Necrotizing Fasciitis Revenue Market Share by Players in 2017
Table Global Necrotizing Fasciitis Key Players Head office and Products Offered
Table Necrotizing Fasciitis Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Necrotizing Fasciitis Market Size by Regions 2013-2018 ($ Millions)
Table Global Necrotizing Fasciitis Market Size Market Share by Regions 2013-2018
Figure Global Necrotizing Fasciitis Market Size Market Share by Regions 2013-2018
Figure Americas Necrotizing Fasciitis Market Size 2013-2018 ($ Millions)
Figure APAC Necrotizing Fasciitis Market Size 2013-2018 ($ Millions)
Figure Europe Necrotizing Fasciitis Market Size 2013-2018 ($ Millions)
Figure Middle East & Africa Necrotizing Fasciitis Market Size 2013-2018 ($ Millions)
Table Americas Necrotizing Fasciitis Market Size by Countries (2013-2018) ($ Millions)
Table Americas Necrotizing Fasciitis Market Size Market Share by Countries (2013-2018)
Figure Americas Necrotizing Fasciitis Market Size Market Share by Countries in 2017
Table Americas Necrotizing Fasciitis Market Size by Type (2013-2018) ($ Millions)
Table Americas Necrotizing Fasciitis Market Size Market Share by Type (2013-2018)
Figure Americas Necrotizing Fasciitis Market Size Market Share by Type in 2017
Table Americas Necrotizing Fasciitis Market Size by Application (2013-2018) ($ Millions)
Table Americas Necrotizing Fasciitis Market Size Market Share by Application (2013-2018)
Figure Americas Necrotizing Fasciitis Market Size Market Share by Application in 2017
Figure United States Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Canada Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Mexico Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Table APAC Necrotizing Fasciitis Market Size by Countries (2013-2018) ($ Millions)
Table APAC Necrotizing Fasciitis Market Size Market Share by Countries (2013-2018)
Figure APAC Necrotizing Fasciitis Market Size Market Share by Countries in 2017
Table APAC Necrotizing Fasciitis Market Size by Type (2013-2018) ($ Millions)
Table APAC Necrotizing Fasciitis Market Size Market Share by Type (2013-2018)
Figure APAC Necrotizing Fasciitis Market Size Market Share by Type in 2017
Table APAC Necrotizing Fasciitis Market Size by Application (2013-2018) ($ Millions)
Table APAC Necrotizing Fasciitis Market Size Market Share by Application (2013-2018)
Figure APAC Necrotizing Fasciitis Market Size Market Share by Application in 2017
Figure China Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Japan Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Korea Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Southeast Asia Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure India Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Australia Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Table Europe Necrotizing Fasciitis Market Size by Countries (2013-2018) ($ Millions)
Table Europe Necrotizing Fasciitis Market Size Market Share by Countries (2013-2018)
Figure Europe Necrotizing Fasciitis Market Size Market Share by Countries in 2017
Table Europe Necrotizing Fasciitis Market Size by Type (2013-2018) ($ Millions)
Table Europe Necrotizing Fasciitis Market Size Market Share by Type (2013-2018)
Figure Europe Necrotizing Fasciitis Market Size Market Share by Type in 2017
Table Europe Necrotizing Fasciitis Market Size by Application (2013-2018) ($ Millions)
Table Europe Necrotizing Fasciitis Market Size Market Share by Application (2013-2018)
Figure Europe Necrotizing Fasciitis Market Size Market Share by Application in 2017
Figure Germany Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure France Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure UK Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Italy Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Russia Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Spain Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Table Middle East & Africa Necrotizing Fasciitis Market Size by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Necrotizing Fasciitis Market Size Market Share by Countries (2013-2018)
Figure Middle East & Africa Necrotizing Fasciitis Market Size Market Share by Countries in 2017
Table Middle East & Africa Necrotizing Fasciitis Market Size by Type (2013-2018) ($ Millions)
Table Middle East & Africa Necrotizing Fasciitis Market Size Market Share by Type (2013-2018)
Figure Middle East & Africa Necrotizing Fasciitis Market Size Market Share by Type in 2017
Table Middle East & Africa Necrotizing Fasciitis Market Size by Application (2013-2018) ($ Millions)
Table Middle East & Africa Necrotizing Fasciitis Market Size Market Share by Application (2013-2018)
Figure Middle East & Africa Necrotizing Fasciitis Market Size Market Share by Application in 2017
Figure Egypt Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure South Africa Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Israel Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Turkey Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure GCC Countries Necrotizing Fasciitis Market Size Growth 2013-2018 ($ Millions)
Figure Global Necrotizing Fasciitis arket Size Forecast (2018-2023) ($ Millions)
Table Global Necrotizing Fasciitis Market Size Forecast by Regions (2018-2023) ($ Millions)
Table Global Necrotizing Fasciitis Market Size Market Share Forecast by Regions
Figure Americas Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure APAC Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Europe Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Middle East & Africa Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure United States Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Canada Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Mexico Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Brazil Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure China Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Japan Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Korea Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Southeast Asia Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure India Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Australia Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Germany Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure France Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure UK Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Italy Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Russia Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Spain Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Egypt Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure South Africa Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Israel Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure Turkey Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Figure GCC Countries Necrotizing Fasciitis Market Size 2018-2023 ($ Millions)
Table Global Necrotizing Fasciitis Market Size Forecast by Type (2018-2023) ($ Millions)
Table Global Necrotizing Fasciitis Market Size Market Share Forecast by Type (2018-2023)
Table Global Necrotizing Fasciitis Market Size Forecast by Application (2018-2023) ($ Millions)
Table Global Necrotizing Fasciitis Market Size Market Share Forecast by Application (2018-2023)
Table Merck Basic Information, Head Office, Major Market Areas and Its Competitors
Table Merck Necrotizing Fasciitis Revenue and Gross Margin (2016-2018)
Figure Merck Necrotizing Fasciitis Market Share (2016-2018)
Table Wockhardt Basic Information, Head Office, Major Market Areas and Its Competitors
Table Wockhardt Necrotizing Fasciitis Revenue and Gross Margin (2016-2018)
Figure Wockhardt Necrotizing Fasciitis Market Share (2016-2018)
Table Atox Bio Basic Information, Head Office, Major Market Areas and Its Competitors
Table Atox Bio Necrotizing Fasciitis Revenue and Gross Margin (2016-2018)
Figure Atox Bio Necrotizing Fasciitis Market Share (2016-2018)
Table Teva Pharmaceutical Industries Basic Information, Head Office, Major Market Areas and Its Competitors
Table Teva Pharmaceutical Industries Necrotizing Fasciitis Revenue and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Industries Necrotizing Fasciitis Market Share (2016-2018)
Table Basilea Pharmaceutica Basic Information, Head Office, Major Market Areas and Its Competitors
Table Basilea Pharmaceutica Necrotizing Fasciitis Revenue and Gross Margin (2016-2018)
Figure Basilea Pharmaceutica Necrotizing Fasciitis Market Share (2016-2018)
Table Melinta Therapeutics Basic Information, Head Office, Major Market Areas and Its Competitors
Table Melinta Therapeutics Necrotizing Fasciitis Revenue and Gross Margin (2016-2018)
Figure Melinta Therapeutics Necrotizing Fasciitis Market Share (2016-2018)


More Publications